- Home
- GGT vs MYO Comparison
GGT vs MYO Comparison
Compare GGT & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGT
- MYO
- Stock Information
- Founded
- GGT 1994
- MYO 2004
- Country
- GGT United States
- MYO United States
- Employees
- GGT N/A
- MYO N/A
- Industry
- GGT Trusts Except Educational Religious and Charitable
- MYO Industrial Specialties
- Sector
- GGT Finance
- MYO Health Care
- Exchange
- GGT Nasdaq
- MYO Nasdaq
- Market Cap
- GGT 128.7M
- MYO 153.0M
- IPO Year
- GGT N/A
- MYO 2017
- Fundamental
- Price
- GGT $4.51
- MYO $4.37
- Analyst Decision
- GGT
- MYO Strong Buy
- Analyst Count
- GGT 0
- MYO 4
- Target Price
- GGT N/A
- MYO $9.75
- AVG Volume (30 Days)
- GGT 59.7K
- MYO 301.7K
- Earning Date
- GGT 01-01-0001
- MYO 05-07-2025
- Dividend Yield
- GGT 15.56%
- MYO N/A
- EPS Growth
- GGT N/A
- MYO N/A
- EPS
- GGT 0.83
- MYO N/A
- Revenue
- GGT N/A
- MYO $32,551,198.00
- Revenue This Year
- GGT N/A
- MYO $32.15
- Revenue Next Year
- GGT N/A
- MYO $17.59
- P/E Ratio
- GGT $6.90
- MYO N/A
- Revenue Growth
- GGT N/A
- MYO 69.17
- 52 Week Low
- GGT $4.32
- MYO $2.51
- 52 Week High
- GGT $7.00
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- GGT 48.59
- MYO 40.76
- Support Level
- GGT $4.06
- MYO $4.21
- Resistance Level
- GGT $4.59
- MYO $4.62
- Average True Range (ATR)
- GGT 0.16
- MYO 0.34
- MACD
- GGT 0.01
- MYO -0.01
- Stochastic Oscillator
- GGT 70.83
- MYO 41.34
About GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).